Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Metastasis02:30

Metastasis

5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer02:18

Cancer

48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1 :: RELA Fusion in Pediatric Proliferative Fasciitis.

The American journal of surgical pathology·2026
Same author

Transcriptomic Subgroups in Soft Tissue Tumors Correlate with Morphologic Subtype, Genomic Features, and Outcome.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Mitochondrial Adaptations Underlying Tetraploidization in Human Cancer, Fungal, and Yeast Models.

Biology·2026
Same author

The Role of RB1 and Secondary Genomic Changes in the Development of Spindle Cell and Pleomorphic Lipomas.

Genes, chromosomes & cancer·2025
Same author

From Primary Cell to Organoid: the proliferative fate international conference and workshop.

Biology open·2025
Same author

JNK Inhibition Overcomes Resistance of Metastatic Tetraploid Cancer Cells to Irradiation-Induced Apoptosis.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jul 15, 2025

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.0K

Tetraploidization Increases the Motility and Invasiveness of Cancer Cells.

Mohamed Jemaà1,2,3, Renee Daams1, Slim Charfi4

  • 1Department of Laboratory Medicine, Translational Cancer Research, Faculty of Medicine, Lund University, 22381 Lund, Sweden.

International Journal of Molecular Sciences
|September 28, 2023
PubMed
Summary

Tetraploid (4n) cancer cells show enhanced migration and invasion, contributing to metastasis despite slower proliferation. Targeting polyploidy is crucial for developing new anti-metastasis therapies.

Keywords:
colon cancerinvasionmetastasismigrationsarcomatetraploidy

More Related Videos

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

7.3K
Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

1.0K

Related Experiment Videos

Last Updated: Jul 15, 2025

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.0K
Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

7.3K
Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

1.0K

Area of Science:

  • Cancer Biology
  • Cell Biology
  • Genetics

Background:

  • Polyploidy and metastasis are linked to poor cancer patient survival.
  • Polyploid cells are implicated in tumorigenesis, but their role in metastasis is less understood.

Purpose of the Study:

  • To investigate the metastatic potential of tetraploid (4n) cancer cells compared to diploid (2n) cells.
  • To explore the clinical relevance of polyploidy in cancer metastasis.

Main Methods:

  • Generated diploid (2n) and tetraploid (4n) clones from malignant fibrous histiocytoma (MFH) and colon carcinoma (RKO) cell lines.
  • Utilized in vitro assays (wound healing, OrisTM, video microscopy, Boyden chamber, xCELLigence RTCA) to assess cell migration and invasion.
  • Evaluated in vivo metastatic potential using tail vein injection in mice and analyzed chromosome aberrations in clinical cancer samples.

Main Results:

  • Tetraploid cells exhibited a significant advantage in migration and invasion in vitro, despite reduced proliferation rates.
  • Tetraploid clones demonstrated preferential metastatic potential in vivo, leading to lung tumor formation.
  • Analysis of the Mitelman Database revealed an increased prevalence of polyploid karyotypes in metastatic tumors compared to primary tumors.

Conclusions:

  • Tetraploid cancer cells possess enhanced migratory and invasive capabilities, contributing to their metastatic potential.
  • Polyploidy represents a clinically relevant subpopulation in cancer metastasis.
  • Targeting polyploidy in preclinical studies is a strategic approach for developing novel anti-metastasis therapies.